FAK in cancer: mechanistic findings and clinical applications.

Articles citing FAK in cancer: mechanistic findings and clinical applications.

Title / Author	Year
The delivery of therapeutic oligonucleotides RL Juliano Nucleic acids research 44 (14), 6518-6548	2016
Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin β1/FAK signaling E Hirata, MR Girotti, A Viros, S Hooper, B Spencer-Dene, M Matsuda, ... Cancer cell 27 (4), 574-588	2015
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy H Jiang, S Hegde, BL Knolhoff, Y Zhu, JM Herndon, MA Meyer, ... Nature medicine 22 (8), 851	2016
FAK signaling in human cancer as a target for therapeutics BY Lee, P Timpson, LG Horvath, RJ Daly Pharmacology & therapeutics 146, 132-149	2015
Epithelial–mesenchymal transition: a new target in anticancer drug discovery F Marcucci, G Stassi, R De Maria Nature reviews Drug discovery 15 (5), 311	2016
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy J Pol, E Vacchelli, F Aranda, F Castoldi, A Eggermont, I Cremer, ... Oncoimmunology 4 (4), e1008866	2015
Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer R Thakur, R Trivedi, N Rastogi, M Singh, DP Mishra Scientific reports 5, 10194	2015
Emerging roles of focal adhesion kinase in cancer YL Tai, LC Chen, TL Shen BioMed research international 2015	2015
Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights H Yoon, JP Dehart, JM Murphy, STS Lim Journal of Histochemistry & Cytochemistry 63 (2), 114-128	2015
FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3–CCL2 signaling X Yang, Y Lin, Y Shi, B Li, W Liu, W Yin, Y Dang, Y Chu, J Fan, R He Cancer research 76 (14), 4124-4135	2016
PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion MC Caino, JC Ghosh, YC Chae, V Vaira, DB Rivadeneira, A Faversani, ... Proceedings of the National Academy of Sciences 112 (28), 8638-8643	2015
Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin M Theodosiou, M Widmaier, RT Böttcher, E Rognoni, M Veelders, ... Elife 5, e10130	2016
Loss of fibronectin from the aged stem cell niche affects the regenerative capacity of skeletal muscle in mice L Lukjanenko, MJ Jung, N Hegde, C Perruisseau-Carrier, E Migliavacca, ... Nature medicine 22 (8), 897	2016
CXCL12/CXCR4 activation by cancer‐associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer D Izumi, T Ishimoto, K Miyake, H Sugihara, K Eto, H Sawayama, T Yasuda, ... International journal of cancer 138 (5), 1207-1219	2016
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression KA Cohen-Solal, RK Boregowda, A Lasfar Molecular cancer 14 (1), 137	2015
Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer M Gugnoni, V Sancisi, G Manzotti, G Gandolfi, A Ciarrocchi Cell death & disease 7 (12), e2520	2016
Mechanisms of selective autophagy in normal physiology and cancer JD Mancias, AC Kimmelman Journal of molecular biology 428 (9), 1659-1680	2016
Focal adhesion kinase signaling in unexpected places EG Kleinschmidt, DD Schlaepfer Current opinion in cell biology 45, 24-30	2017
MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1 G Zhang, J Li, H Zhou, H Xiao, Y Li, T Zhou Journal of Experimental & Clinical Cancer Research 34 (1), 73	2015
FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β C Gao, G Chen, SF Kuan, DH Zhang, DD Schlaepfer, J Hu Elife 4, e10072	2015

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.